Back to Journals » Hepatic Medicine: Evidence and Research » Volume 9

Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy

Total article views   Abstract views HTML views PDF downloads Totals
6,252 Dovepress* 4,645 846+ 979 5,491
PubMed Central* 0 761 139 761
Totals 4,645 1,607 1,118 6,252
*Since 25 September 2017
+Since July 2016

View citations on PubMed Central and Google Scholar